- Ticker
- AKBM.OL
- Price
- 67.00
- Stock movement up
- +2.00 (3.08%)
- Company name
- Aker Biomarine AS
- Exchange
- (OL ,
- Currency
- NOK )
- Sector
- Consumer Defensive >Packaged Foods
- Market cap
- 5.87B
- Ent value
- -
- Price/Sales
- 21.44
- Price/Book
- 15.43
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 4346.62
- Forward P/E
- 20.81
- PEG
- -
- EPS growth
- -
- 1 year return
- 66.67%
- 3 year return
- -12.32%
- 5 year return
- 122.45%
- 10 year return
- 6.96%
Last updated: 2024-04-09
DIVIDENDS
AKBM.OL does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 4346.62 |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | 441.33 |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 21.44 |
| Price to Book | 15.43 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 87.65M |
| EPS (TTM) | 0.02 |
| FCF per share (TTM) | -0.80 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 273.93M |
| Gross profit (TTM) | 102.68M |
| Operating income (TTM) | 10.96M |
| Net income (TTM) | 1.35M |
| EPS (TTM) | 0.02 |
| EPS (1y forward) | 3.22 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 37.49% |
| Operating margin (TTM) | 4.00% |
| Profit margin (TTM) | 0.49% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 0.00 |
| Net receivables | 0.00 |
| Total current assets | 278.50M |
| Goodwill | 94.60M |
| Intangible assets | 68.00M |
| Property, plant and equipment | 0.00 |
| Total assets | 796.60M |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 94.00M |
| Total liabilities | 416.10M |
| Shareholder's equity | 380.50M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -21.47M |
| Capital expenditures (TTM) | 130.61M |
| Free cash flow (TTM) | -69.90M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 0.36% |
| Return on Assets | 0.17% |
| Return on Invested Capital | 0.19% |
| Cash Return on Invested Capital | -10.03% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 65.00 |
| Daily high | 67.50 |
| Daily low | 63.80 |
| Daily Volume | 55K |
| All-time high | 127.96 |
| 1y analyst estimate | 43.05 |
| Beta | 0.66 |
| EPS (TTM) | 0.02 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 25 Apr 2024 |
Downside potential
Loading...
Downside potential data
| AKBM.OL | S&P500 | |
| Current price drop from All-time high | -47.64% | -0.85% |
| Highest price drop | -99.21% | -56.47% |
| Date of highest drop | 13 Aug 2012 | 9 Mar 2009 |
| Avg drop from high | -70.35% | -11.35% |
| Avg time to new high | 217 days | 13 days |
| Max time to new high | 3655 days | 1805 days |
COMPANY DETAILS
Marketcap
5.87B
Marketcap category
Mid-cap
Description
Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates through two segments, Ingredients and Brands. It provides Superba, a krill-based ingredients for nutraceutical, including phospholipid complex of choline, omega-3s, and antioxidant astaxanthin; QRILL Aqua, a krill-based ingredients for aquaculture; and QRILL Pet, a krill-based ingredients animal feed application. The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste and re-use materials. The company was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.
Employees
0
Investor relations
-
SEC filings
CEO
Country
Norway
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found